Case Study: Leading Pharma Company creates a COVID-19-immune incentive compensation plan with Axtria

Creating A COVID-19 Immune Incentive Compensation Plan

Leading Pharma Company partnered with Axtria during the COVID-19 lockdowns to address a major disruption in incentive compensation. With weak field productivity, detailing restrictions, and growing sales team concerns around health and income security, the company needed a more resilient incentive approach to keep reps motivated.

Axtria implemented a COVID-19-immune incentive compensation plan designed to withstand pandemic-driven business fluctuations. The solution helped maintain continuous motivation through balanced payouts and attractive rewards, while also insulating the program from market and geographic variability during the COVID-19 period.